You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
方盛製藥(603998.SH):力爭在未來5-10年時間內,打造3個10億大產品、3個5億大產品、8個超億產品
格隆匯 03-09 14:26

格隆匯3月9日丨方盛製藥(603998.SH)於2023年3月7日接受老虎太平洋基金的調研並表示,公司將聚焦主業,全力做好創新中藥的研發與銷售工作,豐富產品矩陣,着力提升管理水平,為公司健康、持續、穩健發展奠定良好基礎。具體而言,將抓住中醫藥復興的關鍵時刻,實施“338”大產品打造計劃,力爭在未來5-10年時間內,打造3個10億大產品、3個5億大產品、8個超億產品,上述產品集羣主要是根據公司在產藥品的產品綜合競爭力排名選取的,後續可能根據實際情況進行動態微調。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account